These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8195643)
21. Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Marchbank T; Chinery R; Hanby AM; Poulsom R; Elia G; Playford RJ Am J Pathol; 1996 Mar; 148(3):715-22. PubMed ID: 8774127 [TBL] [Abstract][Full Text] [Related]
22. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
23. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer. Higashiyama M; Monden T; Tomita N; Murotani M; Kawasaki Y; Morimoto H; Murata A; Shimano T; Ogawa M; Mori T Br J Cancer; 1990 Dec; 62(6):954-8. PubMed ID: 2257226 [TBL] [Abstract][Full Text] [Related]
24. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Sclabas GM; Uwagawa T; Schmidt C; Hess KR; Evans DB; Abbruzzese JL; Chiao PJ Cancer; 2005 Jun; 103(12):2485-90. PubMed ID: 15861417 [TBL] [Abstract][Full Text] [Related]
25. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565 [TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA. Yamamoto T; Nakamura Y; Nishide J; Emi M; Ogawa M; Mori T; Matsubara K Biochem Biophys Res Commun; 1985 Oct; 132(2):605-12. PubMed ID: 3877508 [TBL] [Abstract][Full Text] [Related]
27. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Ogawa M Clin Biochem; 1988 Jan; 21(1):19-25. PubMed ID: 2449986 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in gynecologic tumors. Ueda G; Shimizu C; Tanaka Y; Inoue M; Tanizawa O; Ogawa M; Mori T Gynecol Oncol; 1989 Jan; 32(1):37-40. PubMed ID: 2462532 [TBL] [Abstract][Full Text] [Related]
29. Expression of human pancreatic secretory trypsin inhibitor in Saccharomyces cerevisiae. Izumoto Y; Sato T; Yamamoto T; Yoshida N; Kikuchi N; Ogawa M; Matsubara K Gene; 1987; 59(2-3):151-9. PubMed ID: 3325337 [TBL] [Abstract][Full Text] [Related]
30. Differences in stimulatory effects between rat pancreatic secretory trypsin inhibitor-61 and -56 on rat pancreas. Miyasaka K; Funakoshi A; Nakamura R; Kitani K; Uda K; Murata A; Ogawa M Jpn J Physiol; 1989; 39(6):891-9. PubMed ID: 2632901 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739 [TBL] [Abstract][Full Text] [Related]
32. Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents. Marchbank T; Mahmood A; Fitzgerald AJ; Domin J; Butler M; Goodlad RA; Elia G; Cox HM; van Heel DA; Ghosh S; Playford RJ Am J Pathol; 2007 Nov; 171(5):1462-73. PubMed ID: 17982125 [TBL] [Abstract][Full Text] [Related]
33. On the cDNA's for two types of rat pancreatic secretory trypsin inhibitor. Horii A; Tomita N; Yokouchi H; Doi S; Uda K; Ogawa M; Mori T; Matsubara K Biochem Biophys Res Commun; 1989 Jul; 162(1):151-9. PubMed ID: 2751646 [TBL] [Abstract][Full Text] [Related]
34. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Abe M; Yamashita J; Ogawa M Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710 [TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and characterization of genes encoding rat pancreatic cholecystokinin (CCK)-releasing peptide (monitor peptide) and pancreatic secretory trypsin inhibitor (PSTI). Tsuzuki S; Miura Y; Fushiki T; Oomori T; Satoh T; Natori Y; Sugimoto E Biochim Biophys Acta; 1992 Sep; 1132(2):199-202. PubMed ID: 1390891 [TBL] [Abstract][Full Text] [Related]
36. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene. Hirota M; Kuwata K; Ohmuraya M; Ogawa M JOP; 2003 Mar; 4(2):83-8. PubMed ID: 12629264 [TBL] [Abstract][Full Text] [Related]
37. Ribonucleases expressed by human pancreatic adenocarcinoma cell lines. Fernández-Salas E; Peracaula R; Frazier ML; de Llorens R Eur J Biochem; 2000 Mar; 267(5):1484-94. PubMed ID: 10691987 [TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248 [TBL] [Abstract][Full Text] [Related]
39. Production of specific monoclonal antibodies against the active sites of human pancreatic secretory trypsin inhibitor variants by in vitro immunization with synthetic peptides. Böldicke T; Kindt S; Maywald F; Fitzlaff G; Böcher M; Frank R; Collins J Eur J Biochem; 1988 Aug; 175(2):259-64. PubMed ID: 3402453 [TBL] [Abstract][Full Text] [Related]
40. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth. Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]